Found: 12
Select item for more details and to access through your institution.
Chimeric Influenza Virus Replicating Predominantly in the Murine Upper Respiratory Tract Induces Local Immune Responses against Human Immunodeficiency Virus Type 1 in the Genital Tract.
- Published in:
- Journal of Infectious Diseases, 1998, v. 178, n. 5, p. 1359
- By:
- Publication type:
- Article
Influenza viral vectors expressing the Brucella OMP16 or L7/L12 proteins as vaccines against B. abortus infection.
- Published in:
- Virology Journal, 2014, v. 11, n. 1, p. 1, doi. 10.1186/1743-422X-11-69
- By:
- Publication type:
- Article
Intranasal Immunization with the Influenza A Virus Encoding Truncated NS1 Protein Protects Mice from Heterologous Challenge by Restraining the Inflammatory Response in the Lungs.
- Published in:
- Microorganisms, 2021, v. 9, n. 4, p. 690, doi. 10.3390/microorganisms9040690
- By:
- Publication type:
- Article
A Novel Type of Influenza Vaccine: Safety and Immunogenicity of Replication-Deficient Influenza Virus Created by Deletion of the Interferon Antagonist NS1.
- Published in:
- Journal of Infectious Diseases, 2010, v. 201, n. 3, p. 354, doi. 10.1086/649428
- By:
- Publication type:
- Article
The Potential of Influenza HA-Specific Immunity in Mitigating Lethality of Postinfluenza Pneumococcal Infections.
- Published in:
- Vaccines, 2019, v. 7, n. 4, p. 187, doi. 10.3390/vaccines7040187
- By:
- Publication type:
- Article
Sublingual Immunization with a Live Attenuated Influenza A Virus Lacking the Nonstructural Protein 1 Induces Broad Protective Immunity in Mice.
- Published in:
- PLoS ONE, 2012, v. 7, n. 6, p. 1, doi. 10.1371/journal.pone.0039921
- By:
- Publication type:
- Article
Oncolytic Effects of a Novel Influenza A Virus Expressing Interleukin-15 from the NS Reading Frame.
- Published in:
- PLoS ONE, 2012, v. 7, n. 5, p. 1, doi. 10.1371/journal.pone.0036506
- By:
- Publication type:
- Article
Single HA2 Mutation Increases the Infectivity and Immunogenicity of a Live Attenuated H5N1 Intranasal Influenza Vaccine Candidate Lacking NS1.
- Published in:
- PLoS ONE, 2011, v. 6, n. 4, p. 1, doi. 10.1371/journal.pone.0018577
- By:
- Publication type:
- Article
Preclinical Evaluation of a Replication-Deficient Intranasal ΔNS1 H5N1 Influenza Vaccine.
- Published in:
- PLoS ONE, 2009, v. 4, n. 6, p. 1, doi. 10.1371/journal.pone.0005984
- By:
- Publication type:
- Article
Tumor cells infected with oncolytic influenza A virus prime natural killer cells for lysis of resistant tumor cells.
- Published in:
- Medical Microbiology & Immunology, 2010, v. 199, n. 2, p. 93, doi. 10.1007/s00430-009-0139-0
- By:
- Publication type:
- Article
A genetically adjuvanted influenza B virus vector increases immunogenicity and protective efficacy in mice.
- Published in:
- Archives of Virology, 2015, v. 160, n. 10, p. 2525, doi. 10.1007/s00705-015-2525-9
- By:
- Publication type:
- Article
IgGκ Signal Peptide Enhances the Efficacy of an Influenza Vector Vaccine against Respiratory Syncytial Virus Infection in Mice.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 14, p. 11445, doi. 10.3390/ijms241411445
- By:
- Publication type:
- Article